BANK VONTOBEL/PUT/STRYKER CORP./320/0.1/20.12.24 Stock

Warrant

DE000VD3SNN1

Real-time Boerse Frankfurt Warrants 04:33:57 2024-07-02 am EDT
1.11 EUR +2.78% Intraday chart for BANK VONTOBEL/PUT/STRYKER CORP./320/0.1/20.12.24
Current month+5.88%
1 month-2.70%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-02 1.11 +2.78%
24-07-01 1.08 +5.88%
24-06-28 1.02 +3.03%
24-06-27 0.99 -1.98%
24-06-26 1.01 -6.48%

Real-time Boerse Frankfurt Warrants

Last update July 02, 2024 at 04:33 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SNN
ISINDE000VD3SNN1
Date issued 2024-04-09
Strike 320 $
Maturity 2024-12-20 (172 Days)
Parity 10 : 1
Emission price 1.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.02
Lowest since issue 0.78
Spread 0.04
Spread %3.48%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
336.5 USD
Average target price
372.9 USD
Spread / Average Target
+10.83%
Consensus